1
Safety and Tolerability of Rilonacept in Muckle-Wells Syndrome (MWS) or Schnitzler Syndrome (SchS)
Condition(s):Muckle-Wells Syndrome; Schnitzler SyndromeLast Updated:May 31, 2012Completed
Muckle-Wells Syndrome: 39 Clinical Trials, Page 1 of 4
Hide Studies Not Open or Pending
2
Efficacy, Safety, and Tolerability of ACZ885 in Patients With Muckle-Wells Syndrome
Condition(s):Muckle Wells SyndromeLast Updated:August 28, 2017Completed
3
A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet’s Disease
Condition(s):Muckle Wells Syndrome; Autoinflammatory; Behcet’s DiseaseLast Updated:July 2, 2017Withdrawn
4
Efficacy and Safety of ACZ885 in Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
Condition(s):Cryopyrin-Associated Periodic Syndromes; Familial Cold Autoinflammatory Syndrome; Muckle Wells Syndrome; Neonatal Onset Multisystem Inflammatory DiseaseLast Updated:November 4, 2016Completed
5
Consequences of Respiratory Devices on Caregivers (CAP2)
Condition(s):Quality of LifeLast Updated:January 12, 2021Recruiting
6
Continued Access to PREVAIL (CAP2) – WATCHMAN Left Atrial Appendage (LAA) Closure Technology
Condition(s):Atrial FibrillationLast Updated:April 24, 2020Completed
7
Efficacy and Safety Study of Canakinumab Administered for 6 Months (24 Weeks) in Japanese Patients With Cryopyrin-associated Periodic Syndromes Followed by an Extension Phase
Condition(s):Cryopyrin-associated Periodic Syndromes; Familial Cold Autoinflammatory Syndrome; Muckle-Wells Syndrome; Neonatal Onset Multisystem Inflammatory DiseaseLast Updated:September 25, 2020Completed
8
The CAP-2 Trial: Effect of Direct Pulp Capping Versus Partial Pulpotomy
Condition(s):Dental Pulp ExposureLast Updated:October 18, 2016Completed
9
Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
Condition(s):Cryopyrin-associated Periodic Syndromes; Familial Cold Autoinflammatory Syndrome; Muckle-Wells Syndrome; Neonatal Onset Multisystem Inflammatory DiseaseLast Updated:September 11, 2018Completed
10
Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease
Condition(s):Cryopyrin-associated Periodic Syndromes; Familial Cold Autoinflammatory Syndrome; Muckle-Wells Syndrome; Neonatal Onset Multisystem Inflammatory DiseaseLast Updated:March 29, 2017Completed